Compare VanEck Video Gaming and eSports ETF (ESPO) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Video Gaming and eSports ETF vs Organon & Co. Common Stock — how do they compare? VanEck Video Gaming and eSports ETF trades at $99.09 (market cap $256.17M), while Organon & Co. Common Stock trades at $13.73 (market cap $3.61B). The key difference: Organon & Co. Common Stock is far larger — about 14.1× VanEck Video Gaming and eSports ETF's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while VanEck Video Gaming and eSports ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Video Gaming and eSports ETF for 68 Days and Organon & Co. Common Stock for 0 Days on average.
| ESPO | OGN | |
|---|---|---|
Market Cap | $256.17M | $3.61B |
Volume | 15,265 | 1,808,049 |
Sector | Sector/Thematic | Health |
52-Week High | $116.66 | $13.81 |
52-Week Low | $85.25 | $5.70 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | — | $11.03B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESPO trades at $100.43, up 0.08% today, with a bullish technical signal driven by strong moving average alignment. Key support lies at $97 and resistance at $98–$99. Financial ratios like P/E and P/S are unavailable in current data, limiting fundamental clarity. Recent news coverage is sparse, leaving sentiment largely neutral.
The stock's near-term outlook hinges on upcoming earnings to validate its technical strength. Risks include limited fundamental visibility and market volatility. Institutional positioning data is needed to gauge Wall Street confidence. Upside potential exists if resistance breaks, but caution is warranted without fresh catalysts.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About VanEck Video Gaming and eSports ETF
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
